Human platelets

Developed for: cardiac valvular defect
Investigated by: Cellphire Therapeutics, Inc. · U.S. Army Medical Research and Development Command

today NCT04709705 · Ph 2/3

20222023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2/3	NCT04709705	Oct 2021 → May 2025	cardiac valvular defect	Cellphire Therapeutics, Inc.	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Human platelets	ClinicalTrials.gov intervention name — accepted as the source's own label NCT04709705 ↗